Erratum: MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (17438–17443) DOI: 10.1073/pnas.1903150116)

Gayathri Srinivasan, Elizabeth A. Williamson, Kimi Kong, Aruna S. Jaiswal, Guangcun Huang, Hyun Suk Kim, Orlando Schärer, Weixing Zhao, Sandeep Burma, Patrick Sung, Robert Hromas

Producción científica: Comment/debaterevisión exhaustiva

Resumen

Correction for “MEDICAL SCIENCES Correction for “MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers,” by Gayathri Srinivasan, Elizabeth A. Williamson, Kimi Kong, Aruna S. Jaiswal, Guangcun Huang, Hyun-Suk Kim, Orlando Schärer, Weixing Zhao, Sandeep Burma, Patrick Sung, and Robert Hromas, which was first published August 8, 2019; 10.1073/pnas.1903150116 (Proc. Natl. Acad. Sci. U.S.A. 116, 17438-17443). The authors note that the grant number for the Cancer Prevention and Research Institute of Texas Research Training Award to G.S. should instead appear as RP170345, rather than RP17035.

Idioma originalEnglish (US)
Páginas (desde-hasta)8658
Número de páginas1
PublicaciónProceedings of the National Academy of Sciences of the United States of America
Volumen117
N.º15
DOI
EstadoPublished - abr 14 2020

ASJC Scopus subject areas

  • General

Huella

Profundice en los temas de investigación de 'Erratum: MiR223-3p promotes synthetic lethality in BRCA1-deficient cancers (Proceedings of the National Academy of Sciences of the United States of America (2019) 116 (17438–17443) DOI: 10.1073/pnas.1903150116)'. En conjunto forman una huella única.

Citar esto